James, living with HIV. Compensated by ViiV Healthcare.
James, living with HIV.
Compensated by ViiV Healthcare.
Information for ASO/CBO professionals
INDICATION
RUKOBIA, in combination with other antiretrovirals (ARVs), is indicated to treat HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current ARV regimen due to resistance, intolerance, or safety considerations.
RUKOBIA works with other HIV-1 treatments to help your clients whose treatment is no longer working and who have exhausted many other treatment options.
RUKOBIA may be right for your clients with multi-drug resistant HIV whose regimens are not working and who have few treatment options left to manage HIV-1 because:
- They have been on several HIV-1 treatment regimens in the past and the virus became resistant
- They were not able to tolerate side effects with their current medications
- They have other safety concerns why they cannot take their existing treatment regimen, potentially including drug interactions
To connect with a ViiV Healthcare professional near you, call 1-877-844-8872
Resources for ASO and CBO professionals
Learn more about RUKOBIA and how to talk to your clients about this treatment option.
ASO AND CBO BROCHURE
A helpful overview for you with more information about RUKOBIA.
PATIENT BROCHURE
A guide for your clients with more information on RUKOBIA.
IS RUKOBIA RIGHT FOR YOUR CLIENTS?
Learn how RUKOBIA may help your clients whose current treatment is no longer working.
ASO=AIDS service organization; CBO=community-based organization.
Sign up to receive more valuable information about RUKOBIA.
FSTWCNT230035
